Up-regulation of γ-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: Implications for Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Free Radical Biology and Medicine

• Publication date

  2006-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.FREERADBIOMED.2005.12.023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 4-Hydroxynonenal increases gamma-glutamyl transpeptidase gene expression through mitogen-activated protein kinase pathways.

  2005cited by this paper
• Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO‐mediated pathway not involving peroxynitrite: implications for Parkinson's disease

  2005cited by this paper
• Nitric Oxide Exposure of CC531 Rat Colon Carcinoma Cells Induces γ-glutamyltransferase which May Counteract Glutathione Depletion and Cell Death

  2003cited by this paper
• 4-Hydroxy-2-nonenal increases gamma-glutamylcysteine synthetase gene expression in alveolar epithelial cells.

  2001cited by this paper
• Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity

  2000cited by this paper
• Quinones increase γ-glutamyl transpeptidase expression by multiple mechanisms in rat lung epithelial cells.

  1998cited by this paper
• Conjugates of Catecholamines with Cysteine and GSH in Parkinson's Disease: Possible Mechanisms of Formation Involving Reactive Oxygen Species

  1998cited by this paper
• A one-step fluorometric method for the continuous measurement of monoamine oxidase activity.

  1997cited by this paper
• Irreversible Inhibition of Mitochondrial Complex I by 7‐(2‐Aminoethyl)‐3,4‐Dihydro‐5‐Hydroxy‐2H‐1,4‐Benzothiazine‐3‐Carboxylic Acid (DHBT‐1): A Putative Nigral Endotoxin of Relevance to Parkinson's Disease

  1997cited by this paper
• Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility.

  1997cited by this paper
• Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.

  1996cited by this paper
• Characterization and transplantation of two neuronal cell lines with dopaminergic properties

  1996cited by this paper
• Measurement of gamma-glutamyl transpeptidase and gamma-glutamylcysteine synthetase activities in cells.

  1995cited by this paper
• [7] Measurement of γ-glutamyl transpeptidase and γ-glutamylcysteine synthetase activities in cells

  1995cited by this paper
• Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.

  1994cited by this paper
• Glutathione‐related enzymes in brain in Parkinson's disease

  1994cited by this paper
• gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells.

  1994cited by this paper
• Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase.

  1993cited by this paper
• Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.

  1993cited by this paper
• Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase.

  1993cited by this paper
• New insights into the cause of Parkinson's disease

  1992cited by this paper
• Glutathione deficiency leads to mitochondrial damage in brain.

  1991cited by this paper
• Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.

  1986cited by this paper
• Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney.

  1985cited by this paper
• [47] Glutathione biosynthesis; γ-glutamylcysteine synthetase from rat kidney

  1985cited by this paper

• Multi-omics study identifies diagnostic metabolic signatures of early Parkinson's disease associated with dysregulated glutathione and TCA cycle metabolism.

  2026cites this paper
• Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life span

  2024cites this paper
• Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk

  2020cites this paper
• Non-linear relationship between gamma-glutamyl transferase and type 2 diabetes mellitus risk: secondary analysis of a prospective cohort study

  2020cites this paper
• Preventive treatments to slow substantia nigra damage and Parkinson's disease progression: a critical perspective review.

  2020cites this paper
• Natural compounds in the treatment of Parkinson's disease

  2020cites this paper
• The mercapturic acid pathway

  2019cites this paper
• 5-S-cysteinyl-dopamine a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease.

  2019cites this paper
• A novel mitochondrial-targeting near-infrared fluorescent probe for imaging γ-glutamyl transpeptidase activity in living cells.

  2018cites this paper
• Protective effects of L-theanine against doxorubicin-induced nephrotoxicity in rats.

  2018cites this paper
• Prevention of progression in Parkinson’s disease

  2018cites this paper
• Post-Translational Oxidative Modifications of Mitochondrial Complex I (NADH: Ubiquinone Oxidoreductase): Implications for Pathogenesis and Therapeutics in Human Diseases

  2017cites this paper
• Regulators of mitochondrial complex I activity: A review of literature and evaluation in postmortem prefrontal cortex from patients with bipolar disorder.

  2016cites this paper
• Phosphonate-based irreversible inhibitors of human γ-glutamyl transpeptidase (GGT). GGsTop is a non-toxic and highly selective inhibitor with critical electrostatic interaction with an active-site residue Lys562 for enhanced inhibitory activity.

  2016cites this paper
• Reactive Oxygen Species (ROS) and Cardiac Ischemia and Reperfusion Injury

  2014cites this paper
• A D. melanogaster parkin mutant larval model of Parkinson's Disease

  2013cites this paper
• Protective Effects of Zonisamide Against Rotenone-Induced Neurotoxicity

  2013cites this paper
• Neurodegeneration in Parkinson's Disease: Interactions of Oxidative Stress, Tryptophan Catabolites and Depression with Mitochondria and Sirtuins

  2013cites this paper
• Glutathione metabolism and Parkinson's disease.

  2013cites this paper
• Cytotoxic Activity of Thelesperma megapotamicum Organic Fractions against MCF-7 Human Breast Cancer Cell Line

  2012cites this paper
• S-Glutathionylation: From Molecular Mechanisms to Health Outcomes

  2011cites this paper
• Quantitative Mapping of Reversible Mitochondrial Complex I Cysteine Oxidation in a Parkinson Disease Mouse Model*

  2011cites this paper
• Protective Effects of Emodin and Chrysophanol Isolated from Marine Fungus Aspergillus sp. on Ethanol-Induced Toxicity in HepG2/CYP2E1 Cells

  2011cites this paper
• Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+)

  2011cites this paper
• Evaluation of Markers of Oxidative Stress, Antioxidant Function and Astrocytic Proliferation in the Striatum and Frontal Cortex of Parkinson’s Disease Brains

  2011cites this paper
• Biochemical and structural properties of gamma-glutamyl transpeptidase from Geobacillus thermodenitrificans: an enzyme specialized in hydrolase activity.

  2010cites this paper
• Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma-glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity.

  2010cites this paper
• Anti-breast cancer activity of curcumin on the human oxidation-resistant cells ZR-75-1 with gamma-glutamyltranspeptidase inhibition.

  2010cites this paper
• Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon 4, and hyperhomocysteinemia in neurodegenerative dementias.

  2009cites this paper
• Glutathione—a review on its role and significance in Parkinson's disease

  2009cites this paper
• Interaction Between Retinoids and Eicosanoids: Their Relevance to Cancer Chemoprevention

  2009cites this paper
• Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71.

  2009cites this paper
• Chromatographic and mass spectrometric analysis of glutathione in biological samples.

  2009cites this paper
• Glutathione and apoptosis

  2008cites this paper
• Effect of green tea and (‐)‐epigallocatechin gallate on ethanol‐induced toxicity in HepG2 cells

  2008cites this paper
• Coupling Endoplasmic Reticulum Stress to the Cell Death Program in Dopaminergic Cells: Effect of Paraquat

  2008cites this paper
• Oxidative and nitrative protein modifications in Parkinson's disease.

  2008cites this paper
• 1-methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neurons.

  2007cites this paper
• GSTπ expression mediates dopaminergic neuron sensitivity in experimental parkinsonism

  2007cites this paper
• Differential effects of quercetin and silymarin on arsenite-induced cytotoxicity in two human breast adenocarcinoma cell lines.

  2007cites this paper
• Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: a dynamic model.

  2007cites this paper